Browse Category

Earnings Reports News 9 January 2026 - 10 January 2026

Spotify stock dips after broker target cuts — what to watch before SPOT earnings

Spotify stock dips after broker target cuts — what to watch before SPOT earnings

Spotify shares fell 2.6% to $539.37 Friday after Guggenheim and UBS cut their price targets but kept Buy ratings. The company launched a new podcast studio in Los Angeles and projected podcasts will add $10 billion in value over five years. Investors are watching for signs Spotify can grow revenue without losing subscribers. Fourth-quarter results are due Feb. 10.
JPMorgan Chase stock slips after hours as Apple Card switch sharpens focus on next week’s earnings

JPMorgan Chase stock slips after hours as Apple Card switch sharpens focus on next week’s earnings

JPMorgan Chase shares slipped 0.2% to $329.19 in after-hours trading Friday after the bank agreed to take over the Apple Card from Goldman Sachs, booking a $2.2 billion provision for credit losses. The transition is expected to take up to 24 months, pending regulatory approval. JPMorgan will report earnings Tuesday, as investors watch for signs of rising credit costs and trading trends.
Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

Rocket Lab shares closed up 2.1% Friday to $84.85 and edged higher after hours. SEC filings showed CFO Adam Spice and COO Frank Klein sold shares last week under pre-set plans. Investors await fourth-quarter results, expected in late February. The company recently secured an $816 million contract to build missile-warning satellites.
AMD stock dips after hours as focus shifts from CES to the next catalysts

AMD stock dips after hours as focus shifts from CES to the next catalysts

AMD shares fell 0.7% to $203.17 in after-hours trading Friday, despite the PHLX semiconductor index hitting a record as the S&P 500 closed at an all-time high. The stock moved between $202.88 and $207.27 during the session, with about 24.1 million shares traded. Investors are awaiting AMD’s upcoming results and U.S. inflation data due January 13.
Palantir stock ticks higher after hours as jobs data cools and Feb. 2 earnings loom

Palantir stock ticks higher after hours as jobs data cools and Feb. 2 earnings loom

Palantir Technologies shares rose 0.3% to $177.49 in after-hours trading Friday, following a regular session with 31.2 million shares traded. The move came as U.S. payrolls rose by 50,000 in December, missing forecasts, while the jobless rate fell to 4.4%. Palantir remains below its 50-day moving average of $180.83 and well under its 52-week high of $207.52. The company’s next earnings report is expected Feb. 2.
Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet Class C shares rose about 1% to $329.14 in after-hours trading Friday. CEO Sundar Pichai sold 32,500 Class C shares for roughly $10.4 million on Jan. 7, leaving him with over 2.2 million. The company reports quarterly results Feb. 4. EU regulators are expected to rule by Feb. 10 on Alphabet’s $32 billion Wiz acquisition.
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.
Linde stock ticks up as Feb. 5 earnings date lands — what investors watch next

Linde stock ticks up as Feb. 5 earnings date lands — what investors watch next

Linde plc shares gained 1% to $444.18 Friday ahead of its fourth-quarter results due Feb. 5. The company previously forecast Q4 adjusted EPS below analyst estimates and reported a 3% drop in EMEA volumes, a trend expected to continue. Rival Air Products also rose. Investors await updates on demand and pricing as the S&P 500 hit a record high and materials stocks advanced.
Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius shares rose 1.2% to $98.48 Friday afternoon after swinging above $104 earlier in the session. The move followed gains in chip stocks and AI infrastructure names, with Nvidia up 0.5% and Applied Digital jumping over 17%. Traders are watching Nebius’ plans to offer Nvidia’s Rubin GPUs in late 2026 and its next earnings report, expected Feb. 18.
Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola shares rose 1.4% to $70.33 Friday, topping $70 as investors favored consumer staples after a weaker-than-expected U.S. jobs report. Nonfarm payrolls increased by 50,000 in December, missing forecasts, while unemployment dipped to 4.4%. The Consumer Staples Select Sector SPDR Fund gained 0.9%. Markets await the December CPI report on Jan. 13 and the Fed’s policy meeting later this month.
1 101 102 103 104 105 202

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
Go toTop